Eprosartan 400mg tablets

Страна: Великобритания

Язык: английский

Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активный ингредиент:

Eprosartan mesilate

Доступна с:

Viatris UK Healthcare Ltd

код АТС:

C09CA02

ИНН (Международная Имя):

Eprosartan mesilate

дозировка:

400mg

Фармацевтическая форма:

Oral tablet

Администрация маршрут:

Oral

класс:

No Controlled Drug Status

Тип рецепта:

Valid as a prescribable product

Обзор продуктов:

BNF: 02050502; GTIN: 5016695004907

тонкая брошюра

PACKAGE LEAFLET: INFORMATION FOR THE USER
Eprosartan 300mg
Film-coated Tablets
Eprosartan 400mg
Film-coated Tablets
Eprosartan 600mg
Film-coated Tablets
eprosartan mesilate
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
Keep this leaflet. You may need to read it again
If you have any further questions, ask your doctor or pharmacist
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
WHAT IS IN THIS LEAFLET:
1. WHAT EPROSARTAN IS AND WHAT IT IS USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE EPROSARTAN
3. HOW TO TAKE EPROSARTAN
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE EPROSARTAN
6. CONTENTS OF THE PACK AND OTHER INFORMATION
1. WHAT EPROSARTAN IS AND WHAT IT IS USED FOR
Eprosartan 300mg, 400mg and 600mg film-coated tablets contains
a medicine called eprosartan mesilate. This belongs to a group of
medicines called ‘angiotensin II receptor antagonists’.
This medicine is used to treat high blood pressure, also called
hypertension.
The main cause of high blood pressure is narrowing of the blood
vessels.
This increases the amount of work your heart must do to pump blood
around your body. You may not feel unwell, but if high blood pressure
is
not treated, it can lead to heart disease and stroke.
HOW EPROSARTAN WORKS:
Angiotensin II is a chemical found in the body which makes your
blood vessels contract. This makes it more difficult for blood to pass
through them
This causes your blood pressure to rise
Eprosartan works by preventing the chemical, angiotensin II, from
causing your blood vessels to contract. This has the effect of
lowering
your blood pressure.
You may be given Eprosartan on its own or with another medicine used
to treat high blood pressure. Using both medicines together will lower
your b

Характеристики продукта

OBJECT 1
EPROSARTAN MYLAN 400 MG FILM-COATED TABLETS
Summary of Product Characteristics Updated 05-Jun-2018 | Generics UK
T/A Mylan
1. Name of the medicinal product
Eprosartan Mylan 400 mg Film-coated tablets
2. Qualitative and quantitative composition
Each film-coated tablet contains 490.53 mg of eprosartan mesilate
equivalent to 400 mg of eprosartan.
Excipient with known effect:
28.518 mg of lactose monohydrate per 400 mg tablet.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated Tablet
400 mg: A pink, film coated, capsule shaped, biconvex, bevelled edge
tablet imprinted with 'M EN2' in
black ink on one side of the tablet and blank on the other side.
4. Clinical particulars
4.1 Therapeutic indications
Eprosartan is indicated for the treatment of essential hypertension.
Eprosartan is indicated in adults.
4.2 Posology and method of administration
Posology
The recommended dose is 600 mg eprosartan once daily.
Achievement of maximal blood pressure reduction in most patients may
take 2 to 3 weeks of treatment.
Eprosartan may be used alone or in combination with other
anti-hypertensives (see sections 4.3, 4.4, 4.5
and 5.1). In particular, addition of a thiazide-type diuretic such as
hydrochlorothiazide or a calcium
channel blocker such as sustained release nifedipine has been shown to
have an additive effect with
eprosartan.
Duration of treatment is not limited.
_Geriatric patients _
No dose adjustment is required in the elderly.
_Dosage in hepatically impaired patients _
There is limited experience in patients with hepatic impairment (see
section 4.3).
_Dosage in renally impaired patients_
In patients with moderate or severe renal impairment (creatinine
clearance <60 ml/min), the daily dose
should not exceed 600 mg.
_Paediatric population_
Eprosartan is not recommended for use in children or adolescents due
to lack of data on safety and
efficacy.
Method of administration
For oral use.
Eprosartan may be taken with or without food.
4.3 Contraindications
Hypersensitivity to the active